Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Asparia Glycomics
San Sebastián (Donostia), Gipuzkoa, Spain
- Ownership
- Private
- Development stage
- Other
01
Overview
Asparia Glycomics provides custom glycan synthesis and advanced glycan analysis services, supporting therapeutic and diagnostic research. Their CarboQuant platform enables accurate glycan quantification, primarily for discovery and preclinical research. No direct clinical-stage programs.
- Therapeutic areas
- ImmunologyGastroenterologyInfectious DiseasesOtherOncology
- Modalities
- Small moleculeBiologicEnzymeGlycanPeptides
- Industry
- Drug Discovery Services
02
Partnerships
Collaborations with academic centers, biotechs, diagnostic developers; no major named pharma partnerships disclosed
Beyond the preview
Go deeper on Asparia Glycomics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Asparia Glycomics.